ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE

Pre-Launch

abacavir sulfate; lamivudine; zidovudine

ANDAORALTABLET

Lifecycle

Pre-Launch

Data completeness

1/8 — Limited

ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE (abacavir sulfate; lamivudine; zidovudine) by Viatris (2). Approved for combination with other antiretroviral agents for the treatment of hiv-1 infection.

Drug data last refreshed 1mo ago

Mechanism of Action

Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.

Indications (1)

combination with other antiretroviral agents for the treatment of HIV-1 infection

Company

Worked on ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.